Home / Technology / IBA selected by MD Anderson Cancer Center to supply three

IBA selected by MD Anderson Cancer Center to supply three

Louvain-La-Neuve, Belgium, January 19, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading…

Louvain-La-Neuve, Belgium, January 19, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it has si… [4398 chars]

Source: GlobeNewswire | Published: 2026-01-19T06:00:00Z

Credit: GlobeNewswire

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *